prescription drug prices — Lanton Law Blog

Lanton Law Interviewed by Pharmacy Times Over Prescription Drug Price Executive Order

Lanton Law was quoted in Pharmacy Times’ article titled “President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%.”

healthcare, pharmaceuticals, pharmacy benefit manager, prescription drug costs, PhRMARon LantonMay 14, 2025prescription drug prices, Executive Order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, Most-Favored-Nation (MFN) Pricing, MFN, healthcare, prescription, pharmaceutical, drug manufacturer

Biden Administration Announces First Ten Drugs Selected for Medicare Price Negotiation

The Biden Administration has announced today that Medicare will be able to negotiate drug prices for the first time due to provisions within the Inflation Reduction Act.

healthcare, life sciences, Medicare Part D, pharmaceuticals, prescription drug costsRon LantonAugust 29, 2023Inflation Reduction Act, drug prices, pharmaceuticals, prescription drug prices, Medicare Part D, CMS, HHS

Biden Administration Files Motion Supporting Canadian Drug Imports

The Biden Administration has filed a motion in federal district court for the District of Columbia. The motion seeks to dismiss a lawsuit that aims to prevent prescription drug imports from Canada.

importation, healthcare, life sciences, pharmaceuticals, prescription drug costsRon LantonJune 2, 2021importation, prescription drug prices, District of Columbia, legal, Congress, Canada, PhRMA

Legislation to Play Significant Role in Drug Pricing Across Specialty Pharmacy

Jennifer Nessel of Pharmacy Times has featured Lanton Law in an article titled “Legislation to Play Significant Role in Drug Pricing Across Specialty Pharmacy.”